Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    Open Studies | "Histoplasmosis"
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Unknown  Treatment for Presumed Ocular Histoplasmosis
Condition: Ocular Histoplasmosis
Intervention: Drug: aflibercept
2 Unknown  Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization in Ocular Histoplasmosis Syndrome
Condition: Ocular Histoplasmosis Syndrome
Intervention: Drug: ranibizumab
3 Unknown  Ranibizumab Versus PDT for Presumed Ocular Histoplasmosis
Condition: Presumed Ocular Histoplasmosis (POHS)
Interventions: Drug: ranibizumab;   Drug: verteporfin
4 Not yet recruiting Additive Benefit of the Urine LAM Test to Current TB Diagnostics in HIV Positive Adults in Panama City, Panama
Conditions: Tuberculosis;   HIV;   Histoplasmosis
Intervention: Other: Urine LAM Ag test

Indicates status has not been verified in more than two years